E. E. Holdener
Impact in
- Biochemistry top 10%
- Antioxidant Activity and Oxidative Stress
-
- Cancer Genomics and Diagnostics
Papers in
-
- Retinoids in leukemia and cellular processes 3
- Oncology 3
- Cytokine Signaling Pathways and Interactions 1
- Co-authors
- Wendy B. Bollag (1 shared paper)Genevieve Decoster (2 shared papers)Gerburg M. Stein (1 shared paper)Sophie D. Fosså (2 shared papers)Ulrich Otto (1 shared paper)H Bauer (1 shared paper)Giovanni Martinelli (1 shared paper)George Schneider (1 shared paper)
- Journals
- Annals of Oncology (3 papers)British Journal of Haematology (1 paper)Recent results in cancer research (1 paper)European Journal of Cancer (1 paper)Haematologica (1 paper)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
E. E. Holdener
16 papers receiving 578 citations
Peers
Comparison fields: 5 of 72
- Biochemistry 50
- Cancer Research 117
- Oncology 187
- Statistics and Probability 45
- Hematology 51
Countries citing papers authored by E. E. Holdener
This map shows the geographic impact of E. E. Holdener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. E. Holdener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. E. Holdener more than expected).
Fields of papers citing papers by E. E. Holdener
This network shows the impact of papers produced by E. E. Holdener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. E. Holdener. The network helps show where E. E. Holdener may publish in the future.
Co-authors
The 25 scholars most cited alongside E. E. Holdener, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 185 | |
| 2 | 1990 | 127 | |
| 3 | 1992 | 76 | |
| 4 | 1990 | 47 | |
| 5 | 1993 | 40 | |
| 6 | 1995 | 33 | |
| 7 | 1991 | 23 | |
| 8 | 1984 | 23 | |
| 9 | A prospective comparison of α-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients | 1992 | 15 |
| 10 | 1989 | 13 | |
| 11 | 1985 | 9 | |
| 12 | 1996 | 9 | |
| 13 | 1990 | 4 | |
| 14 | [Malignant pericardial effusion--a sign of unfavorable prognosis?]. | 1986 | 3 |
| 15 | Phase II trial of diaziquone in advanced renal adenocarcinoma. | 1984 | 2 |
| 16 | 1984 | 2 |
About E. E. Holdener
E. E. Holdener is a scholar working on Molecular Biology, Oncology, Epidemiology, Immunology and Surgery, having authored 16 papers that have together received 611 indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (3 papers), Bladder and Urothelial Cancer Treatments (2 papers), Renal cell carcinoma treatment (2 papers), Estrogen and related hormone effects (2 papers), Thyroid Disorders and Treatments (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Breast Cancer Treatment Studies (1 paper) and Chemical Reactions and Isotopes (1 paper). The work is most often cited by research in Biochemistry (50 citations), Cancer Research (117 citations), Oncology (187 citations), Statistics and Probability (45 citations) and Hematology (51 citations). E. E. Holdener has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Wendy B. Bollag, Genevieve Decoster, Gerburg M. Stein, Sophie D. Fosså, Ulrich Otto, H Bauer, Giovanni Martinelli, George Schneider, F Oberling and F. Calabresi. Their work appears in journals such as Annals of Oncology, British Journal of Haematology, Recent results in cancer research, European Journal of Cancer and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.